Between May and November 2020, the agency asked at least six companies to voluntarily recall several lots of extended-release metformin after agency lab testing detected unacceptable levels of NDMA. It comes as the FDA has made a second recall for Nitroglycerin Lingual Spray, which is administered to patients to relieve pain caused by coronary artery […]